Lista de obras -

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting

artículo científico publicado en 2003

A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment

artículo científico publicado en 2010

A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite

artículo científico publicado en 2005

ABO locus O1 allele and risk of myocardial infarction

artículo científico publicado en 2004

Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Ef

artículo científico publicado en 2005

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

artículo científico publicado en 2004

Assessment of Platelet Function in Whole Blood by Multiple Electrode Aggregometry: Transport of Samples Using a Pneumatic Tube SystemThe Authors’ Reply

artículo científico publicado en 2009

Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry

artículo científico publicado en 2010

Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.

artículo científico publicado en 2009

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting

artículo científico publicado en 2009

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

artículo científico publicado en 2010

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

artículo científico publicado en 2009

Endovascular Treatment for Steno-Occlusive Iliac Artery Disease: Safety and Long-Term Outcome

artículo científico publicado en 2017

Images in cardiovascular medicine. Recurrent syncope due to torsades de pointes in a 41-year-old woman with an empty sella, anterior pituitary insufficiency, and a long-QT interval

artículo científico publicado en 2009

Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention

artículo científico publicado en 2008

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

artículo científico publicado en 2009

Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction

artículo científico publicado en 2008

Ischaemic stroke and myocardial infarction in a Caucasian patient with Moya-Moya disease.

artículo científico publicado en 2007

Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting

artículo científico publicado en 2005

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

artículo científico publicado en 2004

Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy

artículo científico publicado en 2011

N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis

artículo científico publicado en 2006

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease

artículo científico publicado en 2006

Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel

artículo científico publicado en 2010

P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose

artículo científico publicado en 2005

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

artículo científico publicado en 2005

Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction

artículo científico publicado en 2009

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

artículo científico publicado en 2005

Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction

artículo científico publicado en 2005

Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin

artículo científico publicado en 2010

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

artículo científico publicado en 2009

Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina

artículo científico publicado en 2005

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel

artículo científico publicado en 2004

Safety and efficacy of a potential treatment algorithm by using manual compression repair and ultrasound-guided thrombin injection for the management of iatrogenic femoral artery pseudoaneurysm in a large patient cohort

artículo científico publicado en 2014

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial

artículo científico publicado en 2005

Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction

artículo científico publicado en 2004

Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting ⬇️

artículo científico publicado el 21 de noviembre de 2003

Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations

artículo científico publicado en 2004

Lista de obras de

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting

A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment

A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite

ABO locus O1 allele and risk of myocardial infarction

Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Ef

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

Assessment of Platelet Function in Whole Blood by Multiple Electrode Aggregometry: Transport of Samples Using a Pneumatic Tube SystemThe Authors’ Reply

Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry

Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

Endovascular Treatment for Steno-Occlusive Iliac Artery Disease: Safety and Long-Term Outcome

Images in cardiovascular medicine. Recurrent syncope due to torsades de pointes in a 41-year-old woman with an empty sella, anterior pituitary insufficiency, and a long-QT interval

Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction

Ischaemic stroke and myocardial infarction in a Caucasian patient with Moya-Moya disease.

Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy

N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease

Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel

P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction

Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel

Safety and efficacy of a potential treatment algorithm by using manual compression repair and ultrasound-guided thrombin injection for the management of iatrogenic femoral artery pseudoaneurysm in a large patient cohort

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial

Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction

Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting ⬇️

Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations